Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Hermann, HP; Pieske, B; Schwarzmüller, E; Keul, J; Just, H; Hasenfuss, G.
Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study.
Lancet. 1999; 353(9161):1321-1323 Doi: 10.1016/S0140-6736(98)06423-X
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Pieske Burkert Mathias
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Pyruvate, as an intermediate in the Krebs cycle, is an important source of energy for myocardium and improves contractility of normal, hypoxic, and postischaemic animal myocardium. We investigated the effect of intracoronary pyruvate in patients with congestive heart failure. METHODS: Haemodynamic measurements were done in eight patients with dilated cardiomyopathy after two 15 min infusions of pyruvate into the left main coronary artery and after saline washout of pyruvate. FINDINGS: There were no significant differences between the two pyruvate concentrations. Application of pyruvate resulted in a 23% increase in cardiac index (p<0.05), a 38% increase in stroke-volume index (p<0.05), and a 36% decrease in pulmonary capillary wedge pressure (p<0.05). Heart rate decreased significantly by 11%. Mean aortic pressure and systemic vascular resistance did not change. Most of the effects of pyruvate were reversed 15 min after the infusion stopped. INTERPRETATION: Pyruvate has the profile of a favourable inotropic substance. Other modes of administration need to be studied.
Find related publications in this database (using NLM MeSH Indexing)
Cardiomyopathy, Dilated - complications
Coronary Vessels - complications
Female - complications
Heart Catheterization - complications
Heart Failure, Congestive - drug therapy
Hemodynamic Processes - drug effects
Humans - drug effects
Infusions, Intra-Arterial - drug effects
Male - drug effects
Middle Aged - drug effects
Pyruvic Acid - administration and dosage

© Med Uni Graz Impressum